312 related articles for article (PubMed ID: 11238046)
1. Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.
Garcia-Rostan G; Camp RL; Herrero A; Carcangiu ML; Rimm DL; Tallini G
Am J Pathol; 2001 Mar; 158(3):987-96. PubMed ID: 11238046
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas.
Rocha AS; Soares P; Fonseca E; Cameselle-Teijeiro J; Oliveira MC; Sobrinho-Simões M
Histopathology; 2003 Jun; 42(6):580-7. PubMed ID: 12786894
[TBL] [Abstract][Full Text] [Related]
3. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.
Garcia-Rostan G; Tallini G; Herrero A; D'Aquila TG; Carcangiu ML; Rimm DL
Cancer Res; 1999 Apr; 59(8):1811-5. PubMed ID: 10213482
[TBL] [Abstract][Full Text] [Related]
4. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
Kim HS; Hong EK; Park SY; Kim WH; Lee HS
Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
[TBL] [Abstract][Full Text] [Related]
5. More frequent beta-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages.
Yanagisawa N; Mikami T; Saegusa M; Okayasu I
Cancer Res; 2001 Jan; 61(1):19-22. PubMed ID: 11196159
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma.
Omholt K; Platz A; Ringborg U; Hansson J
Int J Cancer; 2001 Jun; 92(6):839-42. PubMed ID: 11351304
[TBL] [Abstract][Full Text] [Related]
7. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer.
Ishigaki K; Namba H; Nakashima M; Nakayama T; Mitsutake N; Hayashi T; Maeda S; Ichinose M; Kanematsu T; Yamashita S
J Clin Endocrinol Metab; 2002 Jul; 87(7):3433-40. PubMed ID: 12107263
[TBL] [Abstract][Full Text] [Related]
8. Activation of the beta-catenin gene by interstitial deletions involving exon 3 as an early event in colorectal tumorigenesis.
Murata M; Iwao K; Miyoshi Y; Nagasawa Y; Yabu M; Himeno S; Imanishi K; Ohsawa M; Wada H; Tominaga S; Shimano T; Kobayashi T; Nakamura Y
Cancer Lett; 2000 Oct; 159(1):73-8. PubMed ID: 10974408
[TBL] [Abstract][Full Text] [Related]
9. Absence of mutations in the beta-catenin and adenomatous polyposis coli genes in papillary and follicular thyroid carcinomas.
Miyake N; Maeta H; Horie S; Kitamura Y; Nanba E; Kobayashi K; Terada T
Pathol Int; 2001 Sep; 51(9):680-5. PubMed ID: 11696170
[TBL] [Abstract][Full Text] [Related]
10. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.
Schulten HJ; Al-Maghrabi J; Al-Ghamdi K; Salama S; Al-Muhayawi S; Chaudhary A; Hamour O; Abuzenadah A; Gari M; Al-Qahtani M
Anticancer Res; 2011 Dec; 31(12):4179-83. PubMed ID: 22199277
[TBL] [Abstract][Full Text] [Related]
11. Frequent nuclear accumulation of beta-catenin in pituitary adenoma.
Semba S; Han SY; Ikeda H; Horii A
Cancer; 2001 Jan; 91(1):42-8. PubMed ID: 11148558
[TBL] [Abstract][Full Text] [Related]
12. Mutation and altered expression of beta-catenin during gallbladder carcinogenesis.
Chang HJ; Jee CD; Kim WH
Am J Surg Pathol; 2002 Jun; 26(6):758-66. PubMed ID: 12023580
[TBL] [Abstract][Full Text] [Related]
13. Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines.
Woo DK; Kim HS; Lee HS; Kang YH; Yang HK; Kim WH
Int J Cancer; 2001 Mar; 95(2):108-13. PubMed ID: 11241321
[TBL] [Abstract][Full Text] [Related]
14. CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1.
Devereux TR; Stern MC; Flake GP; Yu MC; Zhang ZQ; London SJ; Taylor JA
Mol Carcinog; 2001 Jun; 31(2):68-73. PubMed ID: 11429783
[TBL] [Abstract][Full Text] [Related]
15. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma.
Park WS; Oh RR; Park JY; Kim PJ; Shin MS; Lee JH; Kim HS; Lee SH; Kim SY; Park YG; An WG; Kim HS; Jang JJ; Yoo NJ; Lee JY
J Pathol; 2001 Apr; 193(4):483-90. PubMed ID: 11276007
[TBL] [Abstract][Full Text] [Related]
17. Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissues.
Tziortzioti V; Ruebel KH; Kuroki T; Jin L; Scheithauer BW; Lloyd RV
Endocr Pathol; 2001; 12(2):125-36. PubMed ID: 11579678
[TBL] [Abstract][Full Text] [Related]
18. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.
Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T
Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413
[TBL] [Abstract][Full Text] [Related]
20. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
